{"nctId":"NCT01445886","briefTitle":"Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis","startDateStruct":{"date":"2011-01"},"conditions":["Nail Psoriasis"],"count":33,"armGroups":[{"label":"Indigo Naturalis Extract in Oil","type":"EXPERIMENTAL","interventionNames":["Drug: Indigo Naturalis Extract in Oil"]},{"label":"Calcipotriol solution","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Calcipotriol Solution"]}],"interventions":[{"name":"Indigo Naturalis Extract in Oil","otherNames":["Lindioil"]},{"name":"Calcipotriol Solution","otherNames":["Calcipotriol"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Nail psoriasis of the matrix and/or of the nail bed in at least one fingernail.\n2. Good general health.\n3. Agreement to avoid pregnancy for the study duration\n\nExclusion Criteria:\n\n1. Concomitant topical treatment (corticosteroids), phototherapy, or any systemic treatment (retinoids, cyclosporine, methotrexate, systemic corticosteroids and biological agents) that could affect nail psoriasis.\n2. Patients with severe hepatic or renal disorders.\n3. Lactating, pregnant or planning pregnancy\n4. Unwillingness to comply with study protocol.\n5. A history of sensitivity to indigo naturalis. -","healthyVolunteers":true,"sex":"ALL","minimumAge":"20 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Single-handed Nail Psoriasis Severity Index (shNAPSI) at 24 Weeks","description":"The nails will be assessed by two dermatologists at baseline and after treatment 4, 8, 12, 16, 20, 24 weeks using single-handed Nail Psoriasis Severity Index (shNAPSI) score. shNAPSI evaluation: Each nail is given a score for nail bed psoriasis (0-4) and nail matrix psoriasis (0-4) , the total of which is the score for that nail (0-8); the range of shNAPSI of one hand is between 0 and 40, with higher score indicating more severe symptoms. Nail bed psoriasis: presence of any of the nail bed features (onycholysis, hemorrhages, hyperkeratosis, \"oil drop\" (salmon patch dyschroma): 0 for none, 1 for 1 quadrant only, 2 for 2 quadrants, 3 for 3 quadrants, and 4 for 4 quadrants. Nail matrix psoriasis: presence of any of the nail matrix features (pitting, leukonychia red spots in the lunula, crumbling): 0 for none, 1 if present in 1 quadrant of the nail, 2 if present in 2 quadrants of the nail, 3 if present in 3 quadrants of the nail, and 4 if present in 4 quadrants of the nail.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.2","spread":"7.83"},{"groupId":"OG001","value":"27.4","spread":"8.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.4","spread":"8.85"},{"groupId":"OG001","value":"20.4","spread":"8.47"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Modified Target NAPSI for the Single Most Severely Affected Nail","description":"The target nail will be assessed by two dermatologists before treatment and at week 4, 8, 12, 16, 20, 24 using modified target NAPSI score (mtNAPSI, 0-96).\n\nmtNAPSI evaluation: a target nail is divided into 4 quadrants and for each quadrant the nail parameters (oil drop, onycholysis, hyperkeratosis, hemorrhages, pitting, leukonychia, red spots on the lunula, and crumbling) are assessed separately: 0 = no sign, 1 = mild, 2 = moderate, and 3 = severe; the range of mtNAPSI is between 0 and 96, with higher score indicating more severe symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.7","spread":"6.17"},{"groupId":"OG001","value":"16.9","spread":"6.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.9","spread":"4.11"},{"groupId":"OG001","value":"9.5","spread":"5.16"}]}]}]},{"type":"SECONDARY","title":"Physician's and Subject's Global Assessment","description":"The Physician's and Subject's Global Assessment (PGA and SGA) will be assessed by two dermatologists and participant himself/herself respectively after treatment 24 weeks.\n\nA 6-point scale was used for both SGA and PGA: 0 = worse, 1 = 0-24% clearing with little or no change, 2 = 25-49% clearing with slight improvement, 3 = 50-74% clearing with moderate improvement, 4 = 75-99% clearing with striking improvement, 5 = cleared. A score between 3 and 5 was considered to be a positive response and a score between 0 and 2 a poor response.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","spread":"0.82"},{"groupId":"OG001","value":"2.5","spread":"1.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":"1.10"},{"groupId":"OG001","value":"2.3","spread":"1.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.9","spread":"0.76"},{"groupId":"OG001","value":"2.6","spread":"1.23"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":33},"commonTop":[]}}}